AI in drug discovery and its clinical relevanceRizwan Qureshi, Tanvir Alam, Hong Yan et al.|Heliyon|2023Cited by 271
Antibody-drug conjugates in lung cancer: dawn of a new era?Niamh Coleman, Xiuning Le|npj Precision Oncology|2023Cited by 116
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective studyMaliazurina B. Saad, Jia Wu, Lingzhi Hong et al.|The Lancet Digital Health|2023Cited by 108
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLCFederica Pecci, Xiuning Le|Clinical Cancer Research|2025Cited by 6